MRI Shrimp Sign in Cerebellar Progressive Multifocal Leukoencephalopathy: Description and Validation of a Novel Observation

References

1. 1.↵
   2. Major EO,
   3. Yousry TA,
   4. Clifford DB

   . Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol 2018;17:467–80 doi:10.1016/S1474-4422(18)30040-1 pmid:29656742

   CrossRefPubMed
2. 2.↵
   2. Ferenczy MW,
   3. Marshall LJ,
   4. Nelson CD, et al

   . Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012;25:471–506 doi:10.1128/CMR.05031-11 pmid:22763635

   Abstract/FREE Full Text
3. 3.↵
   2. Saribas AS,
   3. Ozdemir A,
   4. Lam C, et al

   . JC virus-induced progressive multifocal leukoencephalopathy. Future Virol 2010;5:313–23 doi:10.2217/fvl.10.12 pmid:21731577

   CrossRefPubMed
4. 4.↵
   2. Major EO,
   3. Amemiya K,
   4. Tornatore CS, et al

   . Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5:49–73 doi:10.1128/cmr.5.1.49 pmid:1310438

   Abstract/FREE Full Text
5. 5.↵
   2. Brooks BR,
   3. Walker DL

   . Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299–313 doi:10.1016/S0733-8619(18)31105-8

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Berger JR,
   3. Houff S

   . Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 2006;28:299–305 doi:10.1179/016164106X98198 pmid:16687057

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Ho PR,
   3. Koendgen H,
   4. Campbell N, et al

   . Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies. Lancet Neurol 2017;16:925–33 doi:10.1016/S1474-4422(17)30282-X pmid:28969984

   CrossRefPubMed
8. 8.↵
   2. Zaheer F,
   3. Berger JR

   . Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps. Ther Adv Drug Saf 2012;3:227–39 doi:10.1177/2042098612453849 pmid:25083238

   CrossRefPubMed
9. 9.↵
   2. Gagne F,
   3. Bouchard JP,
   4. Bernier JP

   . Progressive multifocal leukoencephalopathy: observation with predominant pontocerebellar lesions and association with congenital immune deficiency. Acta Neuropathol 1977;38:167–69 doi:10.1007/BF00688566 pmid:878853

   CrossRefPubMed
10. 10.↵
    2. Jones HR Jr.,
    3. Hedley-Whyte ET,
    4. Freidberg SR, et al

    . Primary cerebellopontine progressive multifocal leukoencephalopathy diagnosed premortem by cerebellar biopsy. Ann Neurol 1982;11:199–202 doi:10.1002/ana.410110218 pmid:7073254

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Hodel J,
    3. Darchis C,
    4. Outteryck O, et al

    . Punctate pattern: a promising imaging marker for the diagnosis of natalizumab-associated PML. Neurology 2016;86:1516–23 doi:10.1212/WNL.0000000000002586 pmid:27009257

    Abstract/FREE Full Text
12. 12.↵
    2. Wattjes MP,
    3. Verhoeff L,
    4. Zentjens W, et al

    . Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? J Neurol Neurosurg Psychiatry 2013;84:1176–77 doi:10.1136/jnnp-2013-304986 pmid:23695498

    FREE Full Text
13. 13.↵
    2. Yadav R,
    3. Ramdas M,
    4. Karthik N, et al

    . “Hot cross bun” sign in HIV-related progressive multifocal leukoencephalopathy. Neurol India 2011;59:293–94 doi:10.4103/0028-3886.79149 pmid:21483137

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Padmanabhan S,
    3. Cherian A,
    4. Iype T, et al

    . Hot cross bun sign in HIV-related progressive multifocal leukoencephalopathy. Ann Indian Acad Neurol 2013;16:672–73 doi:10.4103/0972-2327.120479 pmid:24339604

    CrossRefPubMed
15. 15.↵
    2. Lee YC,
    3. Liu CS,
    4. Wu HM, et al

    . The “hot cross bun” sign in the patients with spinocerebellar ataxia. Eur J Neurol 2009;16:513–16 doi:10.1111/j.1468-1331.2008.02524.x pmid:19187260

    CrossRefPubMed
16. 16.↵
    2. Soares-Fernandes JP,
    3. Ribeiro M,
    4. Machado A

    . “Hot cross bun” sign in variant Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2009;30:E37 doi:10.3174/ajnr.A1335 pmid:19279286

    CrossRefPubMed
17. 17.↵
    2. Muqit MM,
    3. Mort D,
    4. Miskiel KA, et al

    . “Hot cross bun” sign in a patient with parkinsonism secondary to presumed vasculitis. J Neurol Neurosurg Psychiatry 2001;71:565–66 doi:10.1136/jnnp.71.4.565 pmid:11601421

    FREE Full Text
18. 18.↵
    2. Berger JR,
    3. Aksamit AJ,
    4. Clifford DB, et al

    . PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013;80:1430–38 doi:10.1212/WNL.0b013e31828c2fa1 pmid:23568998

    Abstract/FREE Full Text
19. 19.↵
    2. Manto M,
    3. Gruol DL,
    4. Schmahmann J, et al

    . Handbook of the Cerebellum and Cerebellar Disorders. Vol 1. Springer-Verlag; 2013
20. 20.↵
    2. Whiteman ML,
    3. Post MJ,
    4. Berger JR, et al

    . Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993;187:233–40 doi:10.1148/radiology.187.1.8451420 pmid:8451420

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Shah R,
    3. Bag AK,
    4. Chapman PR, et al

    . Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 2010;65:431–39 doi:10.1016/j.crad.2010.03.001 pmid:20451009

    CrossRefPubMed
22. 22.↵
    2. Sahraian MA,
    3. Radue EW,
    4. Eshaghi A, et al

    . Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 2012;19:1060–69 doi:10.1111/j.1468-1331.2011.03597.x pmid:22136455

    CrossRefPubMed
23. 23.↵
    2. Kuker W,
    3. Mader I,
    4. Nagele T, et al

    . Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol 2006;13:819–26 doi:10.1111/j.1468-1331.2006.01362.x pmid:16879291

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Bergui M,
    3. Bradac GB,
    4. Oguz KK, et al

    . Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 2004;46:22–25 doi:10.1007/s00234-003-1115-9 pmid:14593446

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Arai Y,
    3. Tsutsui Y,
    4. Nagashima K, et al

    . Autopsy case of the cerebellar form of progressive multifocal leukoencephalopathy without immunodeficiency. Neuropathology 2002;22:48–56 doi:10.1046/j.0919-6544.2001.00424.x pmid:12030415

    CrossRefPubMed
26. 26.↵
    2. Boster A,
    3. Hreha S,
    4. Berger JR, et al

    . Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol 2009;66:593–99 doi:10.1001/archneurol.2009.31 pmid:19433659

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Ryschkewitsch CF,
    3. Jensen PN,
    4. Monaco MC, et al

    . JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 2010;68:384–91 doi:10.1002/ana.22137 pmid:20818792

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Ikeda J,
    3. Matsushima A,
    4. Ishii W, et al

    . Brain biopsy is more reliable than the DNA test for JC virus in cerebrospinal fluid for the diagnosis of progressive multifocal leukoencephalopathy. Intern Med 2017;56:1231–34 doi:10.2169/internalmedicine.56.7689 pmid:28502942

    CrossRefPubMed
29. 29.↵
    2. Marzocchetti A,
    3. Di Giambenedetto S,
    4. Cingolani A, et al

    . Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 2005;43:4175–77 doi:10.1128/JCM.43.8.4175-4177.2005 pmid:16081969

    Abstract/FREE Full Text
30. 30.↵
    2. De Luca A,
    3. Giancola ML,
    4. Ammassari A, et al

    . The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 2000;182:1077–83 doi:10.1086/315817 pmid:10979902

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Giudici B,
    3. Vaz B,
    4. Bossolasco S, et al

    . Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000;30:95–99 doi:10.1086/313598 pmid:10619739

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Marshall LJ,
    3. Major EO

    . Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol 2010;5:404–17 doi:10.1007/s11481-010-9203-1 pmid:20401541

    CrossRefPubMed
33. 33.↵
    2. Hagerman PJ,
    3. Hagerman RJ

    . Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad Sci 2015;1338:58–70 doi:10.1111/nyas.12693 pmid:25622649

    CrossRefPubMed
34. 34.↵
    2. Koralnik IJ,
    3. Wuthrich C,
    4. Dang X, et al

    . JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 2005;57:576–80 doi:10.1002/ana.20431 pmid:15786466

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Willott RH,
    3. Sunman W,
    4. Munshi SK

    . Progressive multifocal leukoencephalopathy masquerading as cerebellar infarction. Age Ageing 2016;45:564–65 doi:10.1093/ageing/afw052 pmid:27056083

    CrossRefPubMed